OVIT OTC
OncoVista Innovative Therapies, Inc.
1W: +0.0%
1M: +0.0%
3M: -0.0%
YTD: -75.0%
1Y: +0.0%
3Y: -93.3%
5Y: -99.5%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$232K
+50.2% ▲
Capital Expenditures
$4
+0.0% ▲
5Y CAGR: -4.4%
Free Cash Flow
-$232K
+50.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$32K
+93.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $10M | -$2M | -$2M | -$1M | -$3M |
| Depreciation & Amort. | $9K | $7K | $7K | $3K | $477 |
| Stock-Based Comp. | $1M | $228K | $139K | $6K | $995 |
| Change in Working Capital | -$424K | $354K | $274K | $1M | $2M |
| Other Non-Cash Items | -$12M | -$172K | -$345K | -$72K | -$10K |
| Operating Cash Flow | -$555K | -$2M | -$2M | -$467K | -$232K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$3K | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $6M | $204K | $0 | $0 | $0 |
| Investing Cash Flow | $6M | $202K | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$860K | $0 | -$60K | $0 | $200K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$1M | $8K | $257 | $0 | $0 |
| Financing Cash Flow | -$2M | $8K | -$60K | $0 | $200K |
| Net Change in Cash | $3M | -$1M | -$2M | -$467K | -$32K |
| Cash End of Period | $4M | $2M | $512K | $45K | $13K |
| Free Cash Flow | -$555K | -$2M | -$2M | -$467K | -$232K |